Retaglutide is a novel GLP-1 receptor agonist currently under study for the control of type 2 diabetes. This medication works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://neilytkj937437.blogolenta.com/36021451/semaglutide-a-potential-solution-for-diabetes